Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cellular Biomedicine Group Inc (NASDAQ:CBMG)

27.95
Delayed Data
As of Jul 31
 +0.87 / +3.21%
Today’s Change
11.50
Today|||52-Week Range
49.00
+116.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

--
Revenue and IncomeNet Revenues9.4M4.1M564.4K--
 
 
 
 
Cost of Goods Sold0.00763.5K213.2K--
 
 
 
Depreciation And Amortization0.00841.2K1.2M--
 
 
 
 
Operating ExpensesGross Income9.4M2.5M-839.4K--
 
 
 
 
General Expenses1.4M11.3M10.2M--
 
 
 
 
Research And Development0.001.9M2.7M--
 
 
 
Total Operating Expenses1.4M12.9M11.6M--
 
 
 
 
 
Non-Operating ExpensesOperating Income8.0M-8.9M-11.0M--
 
 
 
 
Extraordinary Credit6.1K0.00----
 
 
Extraordinary Charge0.00-4.3M-1.4M--
 
 
 
Interest Expense On Debt58.00257.8K0.00--
 
 
 
Other Expenses1.5M-71.5K72.0K--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.5M-13.5M-12.4M--
 
 
 
 
Income Taxes-113.6K-344.4K0.00--
 
 
 
Discontinued Operations0.000.00-3.1M--
 
 
Net Income9.4M-13.8M-15.5M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.6K5.8M8.6M--
 
 
 
 
Shares To Calculate EPS Diluted15.6K5.8M8.6M--
 
 
 
 
 
Earnings Per ShareEPS$599.00-$2.38-$1.79--
 
 
 
 
EPS Diluted$599.00-$2.38-$1.79--